Peanuts for Cardiometabolic, Brain, and Intestinal Health
Recruiting
N/A
Interventional Study
Prediabetes
Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
Cognition
Microvascular Function
Gut Microbiota
Endothelial Function (Reactive Hyperemia)
Arterial Stiffness, Blood Pressure
Adult
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 20 – 59
- Sex
- Any
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 72 (estimated)
- Sponsor
- Georgia State University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The overall objective of this 14-month randomized crossover study is to seek evidence demonstrating that daily consumption of peanuts and peanut products improve cardiometabolic, cognitive, and intestinal health in a racially diverse prediabetes population.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* men and women
* 20-59 years of age
* BMI: 24.5 - 35.5 kg/m\^2
* Prediabetes (fasting blood glucose levels 100-125 mg/dL and/or HbA1c between 5.7-6.4%)
* Ability to give consent
Exclusion Criteria:
* Allergies to peanuts and peanut products
* Use of insulin, antidiabetic, ant…
Contacts